Phase II clinical trial of multidisciplinary therapy using risk classification based on residual tumor volume and WHO grading for pediatric ependymoma patients (JCCG EPN1501)
Phase 2
- Conditions
- Pediatric ependymoma
- Registration Number
- JPRN-UMIN000023803
- Lead Sponsor
- The Japan Children's Cancer Group(JCCG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)Synchronous or an asynchronous(within 5 years) other cancer 2)Existing heart disease to be treated 3)Pregnant or during breast-feeding 4)Inappropriate inclusion judged by attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method